Association of chronic divalproex sodium use and brain atrophy in Alzheimer's disease

Keyphrases

• Alzheimer's Disease 100%
• Brain Atrophy 100%
• Divalproex Sodium 100%
• Adverse Events 50%
• Seizure 50%
• Sodium 50%
• Schizophrenia 50%
• Neuroprotective Effect 50%
• Cognitive Impairment 50%
• Neurotoxicity 50%
• Anticonvulsant 50%
• Gastrointestinal Diseases 50%
• Bipolar Disorder 50%
• Agitation 50%
• Behavioral Control 50%
• Serious Complications 50%
• Cognitive Decline 50%
• Sedation 50%
• Tiredness 50%
• Neuropsychiatric Conditions 50%
• Medical Conditions 50%
• Mood Stabilizers 50%
• Symptomatic Effect 50%
• Brain Volume Loss 50%
• Divalproex 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Alzheimer's Disease 100%
• Brain Atrophy 100%
• Valproate Semisodium 100%
• Adverse Event 33%
• Anticonvulsive Agent 33%
• Neurotoxicity 33%
• Neuroprotective Agent 33%
• Cognitive Defect 33%
• Gastrointestinal Symptom 33%
• Bipolar Disorder 33%
• Mood Stabilizer 33%
• Fatigue 33%

Neuroscience

• Alzheimer's Disease 100%
• Neuroprotective Agent 50%
• Neurotoxicity 50%
• Cognitive Disorders 50%
• Bipolar Disorder 50%
• Mood Stabilizer 50%
• Behavioral Disorder 50%
• Anticonvulsant 50%